{"id":"W2587744462","doi":"10.1016/s0923-7534(21)00552-4","title":"394TiP KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Response Evaluation Criteria in Solid Tumors; Regimen; Oncology; Internal medicine; Phases of clinical research; Progressive disease; Chemotherapy; Chemotherapy regimen; Surgery; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001203568,0.001413098,0.002149859,0.0004396851,0.0004472871,0.001355808,0.001235191,0.001406571,0.01031437],"category_scores_gemma":[0.0009269578,0.0006821803,0.001484832,0.0003556155,0.000738368,0.001094729,0.0003897214,0.00427471,0.001911441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009348976,"about_ca_system_score_gemma":0.001380411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001466094,"about_ca_topic_score_gemma":0.003913561,"domain_scores_codex":[0.999675,0.0001384094,0.0000155059,0.00005622125,0.00003059575,0.00008424096],"domain_scores_gemma":[0.9995669,0.00007602185,0.00006336024,0.00003801213,0.0000279492,0.0002277277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7938446,0.0570949,0.001956626,0.001473565,0.001740103,0.000147835,0.0001836477,0.001983363,0.0294761,0.0004590112,0.006453744,0.1051864],"study_design_scores_gemma":[0.7245256,0.2645876,0.003886327,0.00005176953,0.0006070299,0.0001243157,0.00005176104,0.001045346,0.002547286,0.0001921843,0.002347816,0.0000329069],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986854,0.002847304,0.0004830339,0.0006559823,0.0003994852,0.002318586,0.001914654,0.0001841296,0.004342834],"genre_scores_gemma":[0.9809488,0.003073031,0.001878788,0.001362479,0.000325111,0.002394326,0.002600537,0.00005643061,0.00736061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01031437,"threshold_uncertainty_score":0.03450501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1396813592620741,"score_gpt":0.4514307971299992,"score_spread":0.3117494378679251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}